International Congress Munich 2014

Saturday, 06.09.2014 Sunday, 07.09.2014 Monday, 08.09.2014 Tuesday, 09.09.2014 Wednesday, 10.09.2014		Sponsored symposia: Boehringer Ingelheim Evening Symposium: "Identifying the unmet needs in asthma: Who, why and how many?" Bayer Expert Forum: “Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in Non-CF Bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.

Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?"

Symposium
Chairs: B. Rottier (Groningen, Netherlands), I. Pavord (Leicester, United Kingdom)
Aims: Drawing on the first presentation of the results of a large randomised placebo controlled trial of intermittent montelukast for preschool asthma, this symposium will review the pathways whereby cysteinyl leukotrienes (cLT) affect airway cells, the clinical relevance of polymorphisms of cLT genes and the evidence to support the use of cLT modifying therapies in paediatric asthma.

Download all media

Intermittent montelukast or preschool wheeze, the results of a randomised controlled trial with stratification for ALOX5 promoter genotype J. Grigg (London, United Kingdom)
Genetics of LT production and activity in asthma I. Sayers (Nottingham, United Kingdom)
Montelukast in paediatric asthma: where we are now and what still needs to be done? A. Bush (London, United Kingdom)